Based on staining with the PD-L1 28-8 assay, the overall prevalence of PD-L1 expression in tumor cells of the cell block cohort was 67.9% and 20.5%, with cutoffs at 1% and 50% respectively. This evidence concerns the gene CD274 and neoplasm.